You have free access to this content

American Journal of Transplantation

Cover image for Vol. 13 Issue 4

April 2013

Volume 13, Issue 4

Pages 827–1114

  1. The AJT Report

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorial
    5. Minireview
    6. Meeting Report
    7. Original Articles
    8. Brief Communications
    9. Case Reports
    10. Reports From the CDC: MMWR
    11. Images in Transplantation
    12. Letters to the Editor
    1. You have free access to this content
      The AJT Report: News and issues that affect organ and tissue transplantation (pages 827–828)

      Sue Pondrom

      Version of Record online: 30 MAR 2013 | DOI: 10.1111/ajt.12231

      Advances in mechanical circulatory devices have challenged heart transplantation as the gold standard therapy for patients with heart failure. This month, we explore just how close we are to tipping the balance between using the devices as bridges to transplantation and as destination therapies. Also this month, we look at possible changes to the OPTN/UNOS heart allocation policy.

  2. Literature Watch

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorial
    5. Minireview
    6. Meeting Report
    7. Original Articles
    8. Brief Communications
    9. Case Reports
    10. Reports From the CDC: MMWR
    11. Images in Transplantation
    12. Letters to the Editor
    1. You have free access to this content
      LITERATURE Watch Implications for transplantation (page 829)

      Vaibhav Upadhyay, Yang-Xin Fu and Jonathan S. Bromberg

      Version of Record online: 30 MAR 2013 | DOI: 10.1111/ajt.12232

      • image

      While the concept of microbes as foreign invaders has been essential in preventing illness in transplantation, recent reports in the fi eld of immunity suggest the possibility that probiotics or targeted antibiotic therapies might be helpful in promoting graft acceptance.

  3. Editorial

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorial
    5. Minireview
    6. Meeting Report
    7. Original Articles
    8. Brief Communications
    9. Case Reports
    10. Reports From the CDC: MMWR
    11. Images in Transplantation
    12. Letters to the Editor
    1. You have free access to this content
      Antibodies Beyond HLA (pages 831–832)

      P. W. Nickerson and D. N. Rush

      Version of Record online: 13 FEB 2013 | DOI: 10.1111/ajt.12160

      The authors summarize the evidence for non-HLA antibodies mediating allograft injury in the context of the fi ndings of Cardinal et al (page 861) that describe the negative impact of a preformed autoantibody on allograft outcomes.

    2. You have free access to this content
      Call It BOS, Call It CLAD—The Need for Prospective Clinical Trials and Elucidating the Mechanism of Extracorporeal Photopheresis (pages 833–834)

      M. L. Barr

      Version of Record online: 30 MAR 2013 | DOI: 10.1111/ajt.12158

      In the context of the promising results seen in the article by Greer et al (page 911), and with the failure of most conventional immunosuppressive agents to have any impact on the clinical course of bronchiolitis obliterans syndrome or chronic lung allograft dysfunction, the author discusses the need for prospective randomized trials to assess the effi cacy of extracorporeal photopheresis as an early stage interventional or prophylactic immunomodulatory strategy and associated cellular mechanisms and biomarkers.

    3. You have free access to this content
      Prolonged Posttransplant Survival With Treatment of Depressive Symptoms (pages 835–836)

      T. Schneekloth

      Version of Record online: 30 MAR 2013 | DOI: 10.1111/ajt.12159

      A psychiatrist comments on the fi ndings of Rogal et al (page 928) and the importance of posttransplant treatment of depressive symptoms to improve long-term survival.

    4. You have free access to this content
      Too Aggressive or Not Aggressive Enough? Should a Metric Change Center Practice? (pages 837–838)

      J. C. Lai and S. Feng

      Version of Record online: 30 MAR 2013 | DOI: 10.1111/ajt.12152

      Should centers measure themselves against a metric quantifying aggressive use of marginal livers, or any other ruler of aggressiveness, to examine and regulate their liver acceptance practice? See article by Garonzik-Wang et al on page 936.

  4. Minireview

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorial
    5. Minireview
    6. Meeting Report
    7. Original Articles
    8. Brief Communications
    9. Case Reports
    10. Reports From the CDC: MMWR
    11. Images in Transplantation
    12. Letters to the Editor
    1. You have free access to this content
      A Thematic Analysis of Quality of Life in Lung Transplant: The Existing Evidence and Implications for Future Directions (pages 839–850)

      J. P. Singer, J. Chen, P. D. Blanc, L. E. Leard, J. Kukreja and H. Chen

      Version of Record online: 22 FEB 2013 | DOI: 10.1111/ajt.12174

      • image

      In this systematic review of health-related quality of life in lung transplantation, the authors use thematic analysis to synthesize and categorize the existing biomedical literature into seven emergent themes, and they highlight limitations in the literature and offer a roadmap for future study.

  5. Meeting Report

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorial
    5. Minireview
    6. Meeting Report
    7. Original Articles
    8. Brief Communications
    9. Case Reports
    10. Reports From the CDC: MMWR
    11. Images in Transplantation
    12. Letters to the Editor
    1. You have free access to this content
      Dynamic Challenges Inhibiting Optimal Adoption of Kidney Paired Donation: Findings of a Consensus Conference (pages 851–860)

      M. L. Melcher, C. D. Blosser, L. A. Baxter-Lowe, F. L. Delmonico, S. E. Gentry, R. Leishman, G. A. Knoll, M. S. Leffell, A. B. Leichtman, D. A. Mast, P. W. Nickerson, E. F. Reed, M. A. Rees, J. R. Rodrigue, D. L. Segev, D. Serur, S. G. Tullius, E. Y. Zavala and S. Feng

      Version of Record online: 7 FEB 2013 | DOI: 10.1111/ajt.12140

      The authors present a report from a consensus conference that aimed to identify and address the full spectrum of theoretical and practical obstacles that have hindered the optimal implementation of kidney paired donation in the United States.

  6. Original Articles

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorial
    5. Minireview
    6. Meeting Report
    7. Original Articles
    8. Brief Communications
    9. Case Reports
    10. Reports From the CDC: MMWR
    11. Images in Transplantation
    12. Letters to the Editor
    1. Basic Science

      You have free access to this content
      Antiperlecan Antibodies Are Novel Accelerators of Immune-Mediated Vascular Injury (pages 861–874)

      H. Cardinal, M. Dieudé, N. Brassard, S. Qi, N. Patey, M. Soulez, D. Beillevaire, F. Echeverry, C. Daniel, Y. Durocher, F. Madore and M. J. Hébert

      Version of Record online: 22 FEB 2013 | DOI: 10.1111/ajt.12168

      • image
      • image
      • image
      • image
      • image
      • image

      This study shows that antibodies to LG3, a fragment of the vascular basement membrane molecule perlecan, are novel accelerators of immune-mediated vascular injury and obliterative remodeling. See editorial by Nickerson and Rush on page 831.

    2. You have free access to this content
      Complement Mediated Renal Inflammation Induced by Donor Brain Death: Role of Renal C5a-C5aR Interaction (pages 875–882)

      M. B. van Werkhoven, J. Damman, M. C. R. F. van Dijk, M. R. Daha, I. J. de Jong, A. Leliveld, C. Krikke, H. G. Leuvenink, H. van Goor, W. J. van Son, P. Olinga, J.-L. Hillebrands and M. A. J. Seelen

      Version of Record online: 7 FEB 2013 | DOI: 10.1111/ajt.12130

      • image
      • image
      • image
      • image
      • image

      Using a precision-cut human kidney slice system, these data suggest that systemic generation of C5a in combination with increased renal C5aR expression in brain-dead donors mediates local renal infl ammation in braindead donor grafts via tubular C5a-C5aR interaction.

    3. You have free access to this content
      Syk-Induced Phosphatidylinositol-3-Kinase Activation in Epstein–Barr Virus Posttransplant Lymphoproliferative Disorder (pages 883–890)

      O. Hatton, S. L. Lambert, L. K. Phillips, M. Vaysberg, Y. Natkunam, C. O. Esquivel, S. M. Krams and O. M. Martinez

      Version of Record online: 7 FEB 2013 | DOI: 10.1111/ajt.12137

      • image
      • image
      • image
      • image
      • image

      The authors demonstrate that small molecule inhibition of the PI3K/Akt pathway reduces tumor formation and tumor burden in a xenotransplantation model of Epstein—Barr virus—positive posttransplant lymphoproliferative disorder.

    4. You have free access to this content
      Islet Survival and Function Following Intramuscular Autotransplantation in the Minipig (pages 891–898)

      A. Sterkers, T. Hubert, V. Gmyr, F. Torres, G. Baud, N. Delalleau, M. C. Vantyghem, J. Kerr-Conte, R. Caiazzo and F. Pattou

      Version of Record online: 15 MAR 2013 | DOI: 10.1111/ajt.12136

      • image
      • image
      • image
      • image
      • image
      • image

      In this study, the authors demonstrate the interest of muscle as a promising alternative site to intraportal infusion for the transplantation of β-cell in a preclinical minipig model.

    5. You have free access to this content
      Reciprocal Interaction Between Intestinal Microbiota and Mucosal Lymphocyte in Cynomolgus Monkeys After Alemtuzumab Treatment (pages 899–910)

      Q. R. Li, C. Y. Wang, C. Tang, Q. He, N. Li and J. S. Li

      Version of Record online: 22 FEB 2013 | DOI: 10.1111/ajt.12148

      • image
      • image
      • image
      • image
      • image
      • image

      Using a cynomolgus monkey model, the authors characterize the temporal change of the gut microbiota composition following lymphocyte depletion with alemtuzumab and demonstrate a central role of mucosal lymphocytes in shaping the gut commensal microbiota, providing novel insight into reciprocal interactions between intestinal microbiota and the mucosal immune system.

    6. Clinical Science

      You have free access to this content
      Phenotyping Established Chronic Lung Allograft Dysfunction Predicts Extracorporeal Photopheresis Response in Lung Transplant Patients (pages 911–918)

      M. Greer, M. Dierich, C. De Wall, H. Suhling, J. Rademacher, T. Welte, A. Haverich, G. Warnecke, P. Ivanyi, S. Buchholz, J. Gottlieb and T. Fuehner

      Version of Record online: 13 FEB 2013 | DOI: 10.1111/ajt.12155

      • image
      • image

      Initiation of extracorporeal photopheresis in established chronic lung allograft syndrome confers survival benefi t in a majority of patients, with factors such as bronchoalveolar lavage neutrophilia, restrictive lung function and rate of decline in graft function predicting the likelihood of response. See editorial by Barr on page 833.

    7. You have free access to this content
      Colonization With Small Conidia Aspergillus Species Is Associated With Bronchiolitis Obliterans Syndrome: A Two-Center Validation Study (pages 919–927)

      S. S. Weigt, C. A. Finlen Copeland, A. Derhovanessian, M. Y. Shino, W. A. Davis, L. D. Snyder, A. L. Gregson, R. Saggar, J. P. Lynch III, D. J. Ross, A. Ardehali, R. M. Elashoff, S. M. Palmer and J. A. Belperio

      Version of Record online: 7 FEB 2013 | DOI: 10.1111/ajt.12131

      • image
      • image

      In two relatively large independent cohorts of lung transplant recipients, the authors fi nd that posttransplant colonization with small conidia (≤3.5μm) Aspergillus species, but not large conidia species, is a risk factor for the development of bronchiolitis obliterans syndrome and death.

    8. You have free access to this content
      Early Treatment of Depressive Symptoms and Long-Term Survival After Liver Transplantation (pages 928–935)

      S. S. Rogal, M. A. Dew, P. Fontes and A. F. DiMartini

      Version of Record online: 20 FEB 2013 | DOI: 10.1111/ajt.12164

      • image

      Untreated depression in the fi rst year after liver transplantation is the strongest predictor of long-term mortality in a prospective cohort of recipients with alcoholic liver disease. See editorial by Schneekloth on page 835.

    9. You have free access to this content
      The Aggressive Phenotype Revisited: Utilization of Higher-Risk Liver Allografts (pages 936–942)

      J. M. Garonzik-Wang, N. T. James, K. J. Van Arendonk, N. Gupta, B. J. Orandi, E. C. Hall, A. B. Massie, R. A. Montgomery, N. N. Dagher, A. L. Singer, A. M. Cameron and D. L. Segev

      Version of Record online: 15 FEB 2013 | DOI: 10.1111/ajt.12151

      • image
      • image
      • image
      • image

      This national study of center-level utilization of various categories of livers suggests that high waitlist disease severity, organ availability, and transplant volume are the main drivers of aggressive utilization of higher-risk livers. See editorial by Lai and Feng on page 837.

    10. You have free access to this content
      Toll-Like Receptor 3 and 7/8 Function Is Impaired in Hepatitis C Rapid Fibrosis Progression Post-Liver Transplantation (pages 943–953)

      J. Howell, R. Sawhney, N. Skinner, P. Gow, P. Angus, D. Ratnam and K. Visvanathan

      Version of Record online: 20 FEB 2013 | DOI: 10.1111/ajt.12165

      • image
      • image
      • image
      • image
      • image
      • image

      In patients who develop rapid HCV-mediated fi brosis progression post—liver transplantation, peripheral blood mononuclear cells have impaired TLR7/8-mediated IFNalpha production by plasmacytoid dendritic cells, impaired TLR7/8-mediated IFNgamma production by NK CD56dim cells and impaired TLR3-mediated pro-infl ammatory cytokine production by monocytes in comparison to HCV patients with slow fi brosis progression.

    11. You have free access to this content
      Class II Alloantibody and Mortality in Simultaneous Liver-Kidney Transplantation (pages 954–960)

      J. G. O'Leary, H. M. Gebel, R. Ruiz, R. A. Bray, J. D. Marr, X. J. Zhou, S. M. Shiller, B. M. Susskind, A. D. Kirk and G. B. Klintmalm

      Version of Record online: 22 FEB 2013 | DOI: 10.1111/ajt.12147

      • image
      • image
      • image

      Preformed class II, but not class I, donor-specifi c alloantibodies are associated with an increased risk of renal antibody-mediated rejection, liver allograft rejection, patient death, liver allograft loss, and renal allograft loss in recipients of simultaneous liver—kidney transplants.

    12. You have free access to this content
      Prospective Randomized Trial of Maintenance Immunosuppression With Rapid Discontinuation of Prednisone in Adult Kidney Transplantation (pages 961–970)

      T. M. Suszynski, K. J. Gillingham, M. D. Rizzari, T. B. Dunn, W. D. Payne, S. Chinnakotla, E. B. Finger, D. E. R. Sutherland, J. S. Najarian, T. L. Pruett, A. J. Matas and R. Kandaswamy

      Version of Record online: 22 FEB 2013 | DOI: 10.1111/ajt.12166

      • image
      • image
      • image
      • image

      A prospective randomized trial comparing three different maintenance immunosuppressive regimens following rapid discontinuation of prednisone reports no differences in recipient and graft survival outcomes or graft function up to 10 years after kidney transplant, but reports differences in rates of drug-related complications such as new-onset diabetes and anemia.

    13. You have free access to this content
      Molecular Diagnosis of Antibody-Mediated Rejection in Human Kidney Transplants (pages 971–983)

      J. Sellarés, J. Reeve, A. Loupy, M. Mengel, B. Sis, A. Skene, D. G. de Freitas, C. Kreepala, L. G. Hidalgo, K. S. Famulski and P. F. Halloran

      Version of Record online: 15 FEB 2013 | DOI: 10.1111/ajt.12150

      • image
      • image
      • image
      • image

      The authors present a novel microarray-based test that detects antibody-mediated rejection in biopsies without knowledge of histology, C4d staining, or donor-specifi c antibody.

    14. You have free access to this content
      Human De Novo Papillary Renal-Cell Carcinomas in a Kidney Graft: Evidence of Recipient Origin With Adenoma-Carcinoma Sequence (pages 984–992)

      J. Verine, M. Varna, P. Ratajczak, M. El-Bouchtaoui, C. Leboeuf, L.-F. Plassa, H. Soliman, W. Sandid, I. Abboud, G. Bousquet, L. Verneuil, M.-N. Peraldi, P. Mongiat-Artus and A. Janin

      Version of Record online: 20 FEB 2013 | DOI: 10.1111/ajt.12163

      • image
      • image
      • image

      Using the unique opportunity provided by the concomitant development of papillary adenoma and papillary renal-cell carcinoma in kidney transplants, this study demonstrates that papillary renal-cell carcinoma may arise from recipient cells according to a multistep tumorigenesis process.

    15. You have free access to this content
      The Impact of Meeting Donor Management Goals on the Development of Delayed Graft Function in Kidney Transplant Recipients (pages 993–1000)

      D. J. Malinoski, M. S. Patel, O. Ahmed, M. C. Daly, S. Mooney, C. O. Graybill, C. E. Foster, A. Salim and on behalf of the United Network for Organ Sharing (UNOS) Region 5 Donor Management Goals (DMG) Workgroup

      Version of Record online: 13 FEB 2013 | DOI: 10.1111/ajt.12090

      The authors report that meeting a bundle of preset critical care endpoints, or donor management goals, independently predicts a lower delayed graft function rate.

    16. You have free access to this content
      The Impact of Deceased Donor Kidney Risk Significantly Varies by Recipient Characteristics (pages 1001–1011)

      E. L. G. Heaphy, D. A. Goldfarb, E. D. Poggio, L. D. Buccini, S. M. Flechner and J. D. Schold

      Version of Record online: 13 FEB 2013 | DOI: 10.1111/ajt.12154

      • image
      • image
      • image

      Results from this study indicate that the effects of donor risk are not uniform for transplant recipients with respect to overall graft loss, which is a critical consideration for informed decision making for transplant candidates.

    17. You have free access to this content
      Trends in the Inactive Kidney Transplant Waitlist and Implications for Candidate Survival (pages 1012–1018)

      M. E. Grams, A. B. Massie, J. D. Schold, B. P. Chen and D. L. Segev

      Version of Record online: 7 FEB 2013 | DOI: 10.1111/ajt.12143

      • image
      • image
      • image

      Since the amendment to OPTN policy 3.5.11, an increasing proportion of kidney transplant waitlist candidates are listed as inactive, and these candidates have higher mortality and lower transplant rates than those with an active status.

    18. You have free access to this content
      Acute Pancreas Allograft Rejection Is Associated With Increased Risk of Graft Failure in Pancreas Transplantation (pages 1019–1025)

      M. Dong, A. K. Parsaik, W. Kremers, A. Sun, P. Dean, M. Prieto, F. G. Cosio, M. J. Gandhi, L. Zhang, T. C. Smyrk, M. D. Stegall and Y. C. Kudva

      Version of Record online: 22 FEB 2013 | DOI: 10.1111/ajt.12167

      • image
      • image

      Acute rejection has long-term negative effects on graft failure post—pancreas transplantation, and protocol biopsies are recommended to improve graft survival, especially in recipients undergoing pancreas transplantation alone or pancreas-after-kidney transplantation.

    19. You have free access to this content
      Randomized Controlled Trial of High-Dose Intradermal Versus Standard-Dose Intramuscular Influenza Vaccine in Organ Transplant Recipients (pages 1026–1033)

      A. Baluch, A. Humar, D. Eurich, A. Egli, A. Liacini, K. Hoschler, P. Campbell, N. Berka, S. Urschel, L. Wilson and D. Kumar

      Version of Record online: 13 FEB 2013 | DOI: 10.1111/ajt.12149

      • image
      • image
      • image

      This trial shows that high-dose intradermal vaccine has similar immunogenicity to standard intramuscular vaccine, and that neither is associated with alloantibody upregulation.

    20. You have free access to this content
      The Utility of Diagnostic Testing for Active Coccidioidomycosis in Solid Organ Transplant Recipients (pages 1034–1039)

      N. Mendoza and J. E. Blair

      Version of Record online: 7 FEB 2013 | DOI: 10.1111/ajt.12144

      The authors summarize the clinical utility of diagnostic testing such as serology, radiographs, cultures and other studies for 27 solid organ transplant recipients with active coccidioidomycosis.

  7. Brief Communications

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorial
    5. Minireview
    6. Meeting Report
    7. Original Articles
    8. Brief Communications
    9. Case Reports
    10. Reports From the CDC: MMWR
    11. Images in Transplantation
    12. Letters to the Editor
    1. You have free access to this content
      A Phase 1, Randomized Ascending Single-Dose Study of Antagonist Anti-Human CD40 ASKP1240 in Healthy Subjects (pages 1040–1046)

      R. Goldwater, J. Keirns, P. Blahunka, R. First, T. Sawamoto, W. Zhang, D. Kowalski, A. Kaibara and J. Holman

      Version of Record online: 28 JAN 2013 | DOI: 10.1111/ajt.12082

      • image
      • image
      • image

      This study reports the safety, tolerability, pharmacokinetic and pharmacodynamic profi le of ASKP1240 following single-dose administration to healthy subjects.

    2. You have full text access to this OnlineOpen article
      Human Monoclonal Antibody MBL-HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study (pages 1047–1054)

      R. T. Chung, F. D. Gordon, M. P. Curry, T. D. Schiano, S. Emre, K. Corey, J. F. Markmann, M. Hertl, J. J. Pomposelli, E. A. Pomfret, S. Florman, M. Schilsky, T. J. Broering, R. W. Finberg, G. Szabo, P. D. Zamore, U. Khettry, G. J. Babcock, D. M. Ambrosino, B. Leav, M. Leney, H. L. Smith and D. C. Molrine

      Version of Record online: 28 JAN 2013 | DOI: 10.1111/ajt.12083

      • image
      • image
      • image
      • image

      Administration of a human monoclonal antibody to HCV E2 glycoprotein during the peritransplant period delays viral rebound after liver transplantation.

    3. You have free access to this content
      Hepatic Artery Ligation for Arterial Rupture Following Liver Transplantation: A Reasonable Option (pages 1055–1062)

      E. Boleslawski, A. F. Bouras, S. Truant, G. Liddo, A. Herrero, B. Badic, M. Audet, M. Altieri, A. Laurent, N. Declerck, F. Navarro, C. Létoublon, P. Wolf, L. Chiche, D. Cherqui and F. R. Pruvot

      Version of Record online: 7 FEB 2013 | DOI: 10.1111/ajt.12135

      • image
      • image

      In some patients, hepatic artery ligation may be the right life-saving option to achieve long-term survival.

    4. You have free access to this content
      No Impact of KIR-Ligand Mismatch on Allograft Outcome in HLA-Compatible Kidney Transplantation (pages 1063–1068)

      T. H. Tran, C. Unterrainer, G. Fiedler, B. Döhler, S. Scherer, A. Ruhenstroth, M. Adamek, D. Middleton and G. Opelz

      Version of Record online: 7 FEB 2013 | DOI: 10.1111/ajt.12134

      • image
      • image

      In contrast to a previous publication, an analysis of 608 HLA-A, -B and -DR compatible kidney transplants shows no signifi cant impact of KIR-HLA mismatching on 10-year allograft survival.

    5. You have free access to this content
      A Survey of Current Practice for Antibody-Mediated Rejection in Heart Transplantation (pages 1069–1074)

      S. Chih, K. J. Tinckam and H. J. Ross

      Version of Record online: 15 FEB 2013 | DOI: 10.1111/ajt.12162

      • image
      • image
      • image

      This survey explores management decisions in antibody-mediated rejection and demonstrates the preference for treatment in the presence of a drop in ejection fraction and/or high antibody-mediated rejection grade.

  8. Case Reports

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorial
    5. Minireview
    6. Meeting Report
    7. Original Articles
    8. Brief Communications
    9. Case Reports
    10. Reports From the CDC: MMWR
    11. Images in Transplantation
    12. Letters to the Editor
    1. You have free access to this content
      Progressive Multifocal Leukoencephalopathy in a Heart Transplant Recipient Following Rituximab Therapy for Antibody-Mediated Rejection (pages 1075–1079)

      R. Y. Loyaga-Rendon, D. O. Taylor and C. E. Koval

      Version of Record online: 14 MAR 2013 | DOI: 10.1111/ajt.12153

      The authors raise the awareness of the association between progressive multiple leukoencephalopathy and monoclonal antibody therapy in the setting of concomitant immunosuppression in transplant recipients.

    2. You have free access to this content
      Donor-Derived Bacteremia in Liver Transplant Recipients Despite Antibiotic Prophylaxis (pages 1080–1083)

      K. E. Doucette, M. Al-Saif, N. Kneteman, L. Chui, G. J. Tyrrell, D. Kumar and A. Humar

      Version of Record online: 7 FEB 2013 | DOI: 10.1111/ajt.12133

      • image

      This case series describes four cases of donor-transmitted bacteremia to liver transplant recipients despite appropriate antibiotic therapy, and discusses the need for further research to optimize the safe utilization of organs from bacteremic donors.

    3. You have free access to this content
      A Novel Mutation of the Ornithine Transcarbamylase Gene Leading to Fatal Hyperammonemia in a Liver Transplant Recipient (pages 1084–1087)

      A. Mukhtar, H. Dabbous, R. El Sayed, F. Aboulfetouh, M. Bahaa, A. Abdelaal, M. Fathy and M. El-Meteini

      Version of Record online: 6 MAR 2013 | DOI: 10.1111/ajt.12146

      • image
      • image

      The authors present the clinical course of an asymptomatic female donor with unrecognized ornithine transcarbamylase defi ciency after right lobe donation along with the recipient fatal course.

    4. You have free access to this content
      Aorto-Mesenteric and Renal Allograft Transplant: A Novel Treatment for Midaortic Syndrome (pages 1088–1092)

      K. Vakili, N. M. Fullington, C. G. Turner, R. P. Cauley, K. M. Potanos, S. Lee, M. Ferguson, J. E. Lock and H. B. Kim

      Version of Record online: 22 FEB 2013 | DOI: 10.1111/ajt.12161

      • image
      • image
      • image
      • image

      The authors present the use of allograft aorta for aortic bypass in a patient with midaortic syndrome and end-stage renal disease with simultaneous renal transplantation.

    5. You have free access to this content
      Transplanted Human Pancreatic Islets After Long-Term Insulin Independence (pages 1093–1097)

      Y. D. Muller, S. Gupta, P. Morel, S. Borot, F. Bettens, M. E. Truchetet, J. Villard, J. D. Seebach, D. Holmberg, C. Toso, J. A. Lobrinus, D. Bosco and T. Berney

      Version of Record online: 7 FEB 2013 | DOI: 10.1111/ajt.12138

      • image
      • image

      The authors perform a morphologic and immunological analysis of human islets transplanted into the liver after over 13 years of insulin independence.

  9. Reports From the CDC: MMWR

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorial
    5. Minireview
    6. Meeting Report
    7. Original Articles
    8. Brief Communications
    9. Case Reports
    10. Reports From the CDC: MMWR
    11. Images in Transplantation
    12. Letters to the Editor
    1. You have free access to this content
      Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedule for Persons Aged 0 Through 18 Years—United States, 2013 (pages 1098–1105)

      Version of Record online: 30 MAR 2013 | DOI: 10.1111/ajt.12233

      • image
      • image

      Updated pediatric immunization guidelines include new links for vaccinations for travel as well as updated references for vaccinating children with primary and secondary immunodefi ciencies.

  10. Images in Transplantation

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorial
    5. Minireview
    6. Meeting Report
    7. Original Articles
    8. Brief Communications
    9. Case Reports
    10. Reports From the CDC: MMWR
    11. Images in Transplantation
    12. Letters to the Editor
    1. CME

      You have free access to this content
      Jaundice Six Months Following Liver Transplantation (pages 1106–1108)

      P. A. Vagefi, P. B. Kelsey, E. P. Hochberg and C. N. Kotton

      Version of Record online: 30 MAR 2013 | DOI: 10.1111/ajt.12052

      • image
      • image
      • image
      Corrected by:

      Erratum: Erratum

      Vol. 14, Issue 1, 243, Version of Record online: 19 DEC 2013

      Corrected by:

      Erratum: Erratum

      Vol. 13, Issue 10, 2779, Version of Record online: 24 SEP 2013

  11. Letters to the Editor

    1. Top of page
    2. The AJT Report
    3. Literature Watch
    4. Editorial
    5. Minireview
    6. Meeting Report
    7. Original Articles
    8. Brief Communications
    9. Case Reports
    10. Reports From the CDC: MMWR
    11. Images in Transplantation
    12. Letters to the Editor
    1. You have free access to this content
      Virtual Histology and the Morphologic Assessment of Cardiac Allograft Vasculopathy (page 1109)

      C. Castellani, A. C. van der Wal, O. J. De Boer, M. Fedrigo, G. Thiene, M. Valente and A. Angelini

      Version of Record online: 7 FEB 2013 | DOI: 10.1111/ajt.12141

    2. You have free access to this content
      Calcineurin Inhibitors and the IL12A Locus Influence Risk of Recurrent Primary Biliary Cirrhosis After Liver Transplantation (pages 1110–1111)

      M. Carbone, G. F. Mells, G. J. Alexander, R. H. Westbrook, M. A. Heneghan, R. N. Sandford and J. M. Neuberger

      Version of Record online: 22 FEB 2013 | DOI: 10.1111/ajt.12132

      • image
    3. You have free access to this content
      BK Virus Genotype Variance and Discordant BK Viremia PCR Assay Results (pages 1112–1113)

      J. Trofe-Clark, T. Sparkes, C. Gentile, V. Van Deerlin, D. Sawinski and R. D. Bloom

      Version of Record online: 22 FEB 2013 | DOI: 10.1111/ajt.12169

    4. You have free access to this content

SEARCH

SEARCH BY CITATION